{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:51Z","timestamp":1788487971943,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical and Translational Research Project of Anhui Province","award":["202427b10020055 and 202427b10020078"],"award-info":[{"award-number":["202427b10020055 and 202427b10020078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02384-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:26:11Z","timestamp":1782206771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the Fibrosis-4 index with thyroid nodule prevalence in women: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ruixia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"8","key":"2384_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2362.2009.02162.x","volume":"39","author":"S Guth","year":"2009","unstructured":"Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13\u00a0MHz) ultrasound examination. Eur J Clin Invest. 2009;39(8):699\u2013706.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2384_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"key":"2384_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev-med-042220-015032","volume":"73","author":"K Kobaly","year":"2022","unstructured":"Kobaly K, Kim CS, Mandel SJ. Contemporary Management of Thyroid Nodules. Annu Rev Med. 2022;73:517\u201328.","journal-title":"Annu Rev Med"},{"issue":"4","key":"2384_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/EJE-09-0410","volume":"161","author":"S Ayturk","year":"2009","unstructured":"Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009;161(4):599\u2013605.","journal-title":"Eur J Endocrinol"},{"key":"2384_CR5","doi-asserted-by":"publisher","first-page":"736972","DOI":"10.3389\/fendo.2021.736972","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang F, Li Y, Yu X, Wang X, Lin Z, Song B, Tian L, Feng C, Shan Z, Teng W. The Relationship and Gender Disparity Between Thyroid Nodules and Metabolic Syndrome Components Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:736972.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2384_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/thy.2021.0686","volume":"32","author":"F Zhang","year":"2022","unstructured":"Zhang F, Teng D, Tong N, Wang G, Li Y, Yu X, Shan Z, Teng W. Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study from China. Thyroid. 2022;32(5):571\u201380.","journal-title":"Thyroid"},{"issue":"3","key":"2384_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","volume":"10","author":"MJ Huang","year":"1995","unstructured":"Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol. 1995;10(3):344\u201350.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2384_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/qjmed\/95.9.559","volume":"95","author":"R Malik","year":"2002","unstructured":"Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002;95(9):559\u201369.","journal-title":"QJM"},{"issue":"2","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/HEP.0000000000000551","volume":"81","author":"L Marino","year":"2025","unstructured":"Marino L, Kim A, Ni B, Celi FS. Thyroid hormone action and liver disease, a complex interplay. Hepatology. 2025;81(2):651\u201369.","journal-title":"Hepatology"},{"key":"2384_CR10","doi-asserted-by":"publisher","first-page":"6853617","DOI":"10.1155\/2018\/6853617","volume":"2018","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhu C, Chen Y, Wang N, Li Q, Han B, Zhao L, Chen C, Zhai H, Lu Y. The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study. Int J Endocrinol. 2018;2018:6853617.","journal-title":"Int J Endocrinol"},{"key":"2384_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fendo.2020.00582","volume":"11","author":"Q Liang","year":"2020","unstructured":"Liang Q, Yu S, Chen S, Yang Y, Li S, Hu C, Huang D, Kuang L, Li D. Association of Changes in Metabolic Syndrome Status With the Incidence of Thyroid Nodules: A Prospective Study in Chinese Adults. Front Endocrinol (Lausanne). 2020;11:582.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2384_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(2):389\u2013e397310.","journal-title":"Gastroenterology"},{"issue":"6","key":"2384_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Torriani MSS, Dieterich FJ, Thomas DT. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"10","key":"2384_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(10):1104\u201312.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2384_CR15","doi-asserted-by":"publisher","first-page":"e70139","DOI":"10.1111\/liv.70139","volume":"45","author":"S Zelber-Sagi","year":"2025","unstructured":"Zelber-Sagi S, Schonmann Y, Weinstein G, Yeshua H. Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort Study. Liver Int. 2025;45(6):e70139.","journal-title":"Liver Int"},{"key":"2384_CR16","doi-asserted-by":"publisher","first-page":"1233083","DOI":"10.3389\/fonc.2023.1233083","volume":"13","author":"L Crudele","year":"2023","unstructured":"Crudele L, Novielli F, De Matteis C, Petruzzelli S, Suppressa P, Berardi E, Antonica G, Piazzolla G, Sabb\u00e0 C, Graziano G, et al. Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects. Front Oncol. 2023;13:1233083.","journal-title":"Front Oncol"},{"issue":"5","key":"2384_CR17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, Oliveira CP, Francque S, Van Gaal L, Schattenberg JM, et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. Am J Gastroenterol. 2017;112(5):740\u201351.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2384_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40618-020-01208-6","volume":"43","author":"E Piantanida","year":"2020","unstructured":"Piantanida E, Ippolito S, Gallo D, Masiello E, Premoli P, Cusini C, Rosetti S, Sabatino J, Segato S, Trimarchi F, et al. The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest. 2020;43(7):885\u201399.","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2384_CR19","first-page":"955","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Yang RX, Nan YM, Wei L, Jia JD, Zhuang H, Shi JP, Li XY, Sun C, et al. Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024). J Clin Transl Hepatol. 2024;12(11):955\u201374.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"2384_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical","year":"2024","unstructured":"EASL-EASD-EASO Clinical. Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"},{"issue":"3","key":"2384_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jclinepi.2003.08.009","volume":"57","author":"ST Brookes","year":"2004","unstructured":"Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57(3):229\u201336.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02384-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:25:24Z","timestamp":1788485124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02384-x","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of The Second Affiliated Hospital of Anhui Medical University (Approval No. YX2026-008(F1)). According to the ethics committee requirement, participants who could be contacted by telephone were required to provide written informed consent; for participants who could not be contacted, the informed consent process was waived by the ethics committee because of the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"256"}}